During Tuesday’s Morning trade, Shares of PG&E Corporation (NYSE:PCG), gained 1.20% to $53.11.
Pacific Gas and Electric Company, declared plans to extend its highly successful Power Pathway training program to comprise a first-ever cohort of active-duty service members. Participants will receive training in gas and electric operations, with PG&E committed to hiring eight of the 15 graduates.
This new training effort will be launched in early 2016 at Bates Technical College in Tacoma, Wash. The program will be exclusively for service members stationed at Joint Base Lewis-McChord (JBLM), a U.S. Army-U.S. Air Force installation located south of Tacoma.
PG&E Corporation, through its partner, Pacific Gas and Electric Company, transmits, delivers, and sells electricity and natural gas to residential, commercial, industrial, and agricultural customers primarily in northern and central California.
Shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN), declined -1.42% to $2.08, during its current trading session.
Moments ago, Trader’s Choice released new research updates concerning several important developing situations counting the following equities: Medifast Inc (MED), Potbelly Corp (PBPB), AMARIN CORPORATION PLC (AMRN) and Idera Pharmaceuticals Inc (IDRA). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Highlights from recently’s reports comprise:
On Friday, November 06, 2015, the NASDAQ Composite ended at 5,147.12, up 0.38%, the Dow Jones Industrial Average edged 0.26% higher, to finish the day at 17,910.33, and the S&P 500 closed at 2,099.20, down 0.03%.
- Medifast Inc’s stock raised by 2.96% to close Friday’s session at USD 31.99. The company’s shares fluctuated in the range of USD 29.88 and USD 31.99. A total of 0.15 million shares exchanged hands, which surpassed its 50-day daily average volume and 52-week average volume of 0.11 million shares each. Over the last three days, Medifast Inc’s shares have advanced 8.37% and in the past one week it has moved up 14.37%. Furthermore, over the last three months, the stock has gained 13.12%. The company has returned 5.89% in the last half year, on a compounded total return basis. Further, the company is trading at a price to earnings ratio of 30.47 and the stock is at a price to book ratio of 4.24. This compares to a historical PE ratio of 20.39. The historical PB ratio is near to 5.03. Additionally, the stock is trading at a price to cash flow ratio of 14.86 and price to sales ratio of 1.42.
- Potbelly Corp’s stock added 3.63% to close Friday’s session at USD 11.99. The company’s shares oscillated between USD 11.38 and USD 12.03. The stock recorded a trading volume of 0.42 million shares, which was above its 50-day daily average volume of 0.30 million shares and above its 52-week average volume of 0.34 million shares. Over the last five days, Potbelly Corp’s shares have advanced 7.05% and in the past one month, it has gained a momentum of 4.35%. In addition, over the last three months, the stock has gained 0.93%. The company has returned 9.20% in the past one month, and 15.50% in the past one year, on a compounded total return basis. Further, the company is trading at a price to earnings ratio of 70.53. This compares to a historical PE ratio of 84.82. Additionally, the company has an Enterprise value of USD 320.50 million with an Enterprise Value to Revenue ratio of 0.88 and Enterprise Value to EBITDA ratio of 9.68
- AMARIN CORPORATION PLC’s stock (ADR) advanced 3.03% to close Friday’s session at USD 2.04. The share price vacillated between USD 1.93 and USD 2.05. The stock recorded a trading volume of 0.99 million shares, which was below its 50-day daily average volume of 1.23 million shares and below its 52-week average volume of 2.58 million shares. Further, the stock has a 52 week range of USD 0.78 - USD 3.33. Over the last three days, AMARIN CORPORATION PLC’s shares have advanced 4.08% and in the past one week it has moved up 7.37%. Moreover, in the last six months, the stock has gained 10.27% and year to date, the shares have picked up 108.23%. On a compounded total return basis, the stock has returned 3.55% in the last half a year, and 126.67% in the past one year. AMARIN CORPORATION PLC’s stock has a market capitalization of USD 372.36 million
- Idera Pharmaceuticals Inc’s stock edged higher by 5.66% to close Friday’s session at USD 3.36. The company’s shares oscillated between USD 3.15 and USD 3.37. The stock recorded a trading volume of 1.41 million shares, which was below its 50-day daily average volume of 1.53 million shares and below its 52-week average volume of 1.85 million shares. Over the last three days, Idera Pharmaceuticals Inc’s shares have advanced 9.45% and in the past one week it has moved up 21.74%. Furthermore, over the last three months, the stock has gained 19.79% and in the past six months, the shares have picked up 21.30%. On a compounded total return basis, the company has returned 20.43% in the past one month. The stock is at a price to book ratio of 3.66. The historical PB ratio is near to 9.64. Additionally, the stock is trading at a price to sales ratio of 5290.57.
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product comprises Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.
Finally, Shares of Genco Shipping & Trading Ltd (NYSE:GNK), lost -8.52%, and is now trading at $1.61.
Genco Shipping & Trading Limited, stated its financial results for the three and nine months ended September 30, 2015.
The following financial review discusses the results for the three and nine months ended September 30, 2015 and September 30, 2014.
Third quarter 2015 and Year-to-Date Highlights
- Recorded a net loss attributable to Genco Shipping & Trading Limited of $66.6 million for the third quarter of 2015
- Basic and diluted loss per share of $0.95;
- Basic and diluted loss of $27.2 million or $0.39 per share, not taking into account the $32.5 million impairment of our holdings in Jinhui Shipping & Transportation Limited (“Jinhui”) and merger related expenses of $6.9 million;
- Reached a new loan facility with a term of about five years, under which the Company anticipates to complete the funding of about $98 million on November 10, 2015;
- Accomplished the merger with Baltic Trading Limited (“Baltic Trading”) on July 17, 2015 under which Genco attained Baltic Trading in a stock-for-stock transaction
- Commenced trading on the NYSE under symbol GNK on July 20, 2015;
- Accomplished amendments for each of Baltic Trading’s facilities on July 14, 2015
- Obtained consent for the merger and relief under certain covenants;
- Took delivery of the Baltic Scorpion, a newbuilding Ultramax vessel, on August 6, 2015;
- Reached a contract to charter the vessel at a rate based on 115.5% of the Baltic Supramax Index for 14 to 18.5 months;
- Took delivery of the Baltic Mantis, the final newbuilding Ultramax vessel to be delivered to the Company under Baltic Trading’s formerly declared agreements with Yangfan Group Co., Ltd., on October 9, 2015;
- Reached a contract to charter the vessel at a rate based on 115% of the Baltic Supramax Index for 14 to 18.5 months.
Genco Shipping & Trading Limited engages in the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels worldwide. It transports iron ore, coal, grain, steel products, and other drybulk cargoes. The company charters its vessels primarily to trading houses, which comprise commodities traders; producers; and government-owned entities.